Overactive Bladder: Clinical Trials

88 trials for Overactive Bladder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

88 completed. 88 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable88Completed 88

Follow Overactive Bladder: new trials by email Literature Review of Overactive Bladder trials Research Report on Overactive Bladder

Trials (filtered) newest first · largest first

All 88 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females
Solifenacin, Tadalafil - Overactive Bladder
Not applicableCompletedAin Shams University802025-05-152025-12-31
Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker
Solifenacin, vitamin D, Standard behavioral therapy - Overactive Bladder, Pediatric Disorder
Not applicableCompletedXing Liu1802024-12-282025-11-25
Usability Study of the FemPulse System
FemPulse System - Overactive Bladder
Not applicableCompletedFemPulse Corporation52024-09-112026-02-06
rTMS in Overactive Bladder
Transcranial Magnetic Stimulation - Overactive Bladder, Overactive Bladder Syndrome
Not applicableCompletedThe Methodist Hospital Research Institute142024-01-082026-03-24
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
Standard number of injection sites, Reduced number of injection sites - Neurogenic Bladder, Lower Urinary Tract Symptoms
Not applicableCompletedThe Methodist Hospital Research Institute782023-10-042025-05-09
Transvaginal Radiofrequency Ablation for Overactive Bladder
Treatment with Morpheus - Overactive Bladder
Not applicableCompletedInMode MD Ltd.172023-06-192024-06-13
Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects
ViXe Xombination, Placebo + Sham - Overactive Bladder
Not applicableCompletedVensica Therapeutics Ltd.482023-06-092024-04-09
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
At home removal, In office removal - Overactive Bladder
Not applicableCompletedThe Cleveland Clinic302023-06-072026-07-23
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
Oral Solifenacin 5mg, Transcutaneous Posterior Tibial Nerve Stimulation (TTNS) - Overactive Bladder, Overactive Bladder Syndrome
Not applicableCompletedEge University342023-04-182023-09-05
Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children
Solifenacin Succinate 5 MG Oral Tablet [Vesicare], Vitamin D3, Standard urotherapy - Overactive Bladder
Not applicableCompletedXing Liu3032023-01-152024-02-06
Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive Bladder
Stabilization exercise+lifestyle recommendation, lifestyle recommendations - Overactive Bladder
Not applicableCompletedAnkara Yildirim Beyazıt University402023-01-152023-07-19
AURA-2: Augmenting Urinary Reflex Activity
Amber UI System - Overactive Bladder, Urge Incontinence
Not applicableCompletedAmber Therapeutics Ltd132022-11-302024-08-12
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
Repetitive transcranial magnetic stimulation, Sham rTMS - Urgency Urinary Incontinence, Overactive Bladder
Not applicableCompletedThe Hong Kong Polytechnic University602022-11-092024-05-03
Management of OAB in Female Patients .
Solfenacin, Mirabegron, Tadalafil 5mg - Overactive Bladder
Not applicableCompletedElsayed Abdelhalim Elsayed3002022-09-142024-04-02
Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
TheraNova Neuromodulation Device - Overactive Bladder
Not applicableCompletedTheranova, L.L.C.32022-02-202024-02-28
Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)
Medtronic Implantable Tibial Neuromodulation (TNM) System - Overactive Bladder
Not applicableCompletedMedtronicNeuro1882022-01-312025-11-21
TEST-ON - Does iStim Reduce Urinary Urgency?
iStim TENS unit and Transvaginal Probe - Overactive Bladder, Urgency-frequency Syndrome
Not applicableCompletedUniversity of California, Los Angeles242021-12-202025-05-06
Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms
TheraNova Neuromodulation System - Overactive Bladder
Not applicableCompletedTheranova, L.L.C.122021-10-282024-02-28
Evaluating a Digital Intervention for Overactive Bladder
NUIG OAB App - Overactive Bladder
Not applicableCompletedNational University of Ireland, Galway, Ireland292021-09-012021-12-27
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms
Non-invasive low-frequency tibial nerve stimulator (TNS-01) - Overactive Bladder
Not applicableCompletedMedtecx Co Ltd.1092021-08-262023-01-18

Showing 20 of 88. Sign in to see all of them.

Narrower conditions

Urinary Bladder, Overactive (88)  ·  Urinary Incontinence, Urge (20)  ·  Urinary Incontinence (14)  ·  Lower Urinary Tract Symptoms (7)  ·  Nocturia (5)  ·  Urinary Incontinence, Stress (3)  ·  Pelvic Floor Disorders (2)  ·  Acute Pain (1)  ·  Alcohol Drinking (1)  ·  Cystitis, Interstitial (1)  ·  Fecal Incontinence (1)  ·  Hyperthermia (1)  ·  Medication Adherence (1)  ·  Motor Activity (1)  ·  Multiple Sclerosis (1)

Broader conditions

Female Urogenital Diseases (88)  ·  Female Urogenital Diseases and Pregnancy Complications (88)  ·  Male Urogenital Diseases (88)  ·  Pathological Conditions, Signs and Symptoms (88)  ·  Signs and Symptoms (88)  ·  Urinary Bladder Diseases (88)  ·  Urogenital Diseases (88)  ·  Urological Manifestations (88)  ·  Urologic Diseases (87)  ·  Lower Urinary Tract Symptoms (81)  ·  Urination Disorders (31)  ·  Urinary Incontinence (17)  ·  Behavior (3)  ·  Nervous System Diseases (3)  ·  Central Nervous System Diseases (2)

Interventions

Solifenacin Succinate (7)  ·  Drug Delivery Systems (3)  ·  Transcutaneous Electric Nerve Stimulation (3)  ·  Behavior Therapy (2)  ·  Neoplasm Staging (2)  ·  Tadalafil (2)  ·  Transcranial Magnetic Stimulation (2)  ·  fesoterodine (2)  ·  mirabegron (2)  ·  Athletic Tape (1)  ·  Biopsy (1)  ·  Cholecalciferol (1)  ·  Electric Stimulation (1)  ·  Estradiol (1)  ·  Estrogens, Conjugated (USP) (1)

Sponsors

MedtronicNeuro (4)  ·  Ankara Yildirim Beyazıt University (3)  ·  Theranova, L.L.C. (3)  ·  University of Aarhus (3)  ·  Ethicon Endo-Surgery (2)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2)  ·  Samsung Medical Center (2)  ·  The Methodist Hospital Research Institute (2)  ·  University of California, Los Angeles (2)  ·  Valencia Technologies Corporation (2)  ·  Vensica Therapeutics Ltd. (2)  ·  Xing Liu (2)  ·  Ain Shams University (1)  ·  Alexandria University (1)  ·  Amber Therapeutics Ltd (1)

Countries

United States (42)  ·  Turkey (Türkiye) (6)  ·  United Kingdom (5)  ·  China (4)  ·  Denmark (4)  ·  Canada (3)  ·  Egypt (3)  ·  Netherlands (3)  ·  South Korea (3)  ·  Belgium (2)  ·  Hong Kong (2)  ·  Portugal (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Czechia (1)

Top investigators

Soeren Hagstroem, MD (2)  ·  Aftab Ahmed Mirza Baig, DPT, MSAPT (1)  ·  Ahmed Elshal (1)  ·  Ahmet Ozgur OY Yeniel (1)  ·  Alexandra Caffrey, BS (1)  ·  Alexis Dieter, MD (1)  ·  Alexis Te, M.D. (1)  ·  Alison Huang, MD (1)  ·  Allen D Andrade, MD (1)  ·  Andrea Staack, MD (1)  ·  Anne L Ackerman, MD, PhD (1)  ·  Anne Miller (1)  ·  Annemarie B Villadsen (1)  ·  Anupreet Dua, MBBS, MRCOG (1)

Results publications

PMID 37811598, PMID 10699609, PMID 12493342, PMID 15621220, PMID 17049716, PMID 19400928, PMID 20035977, PMID 20374659, PMID 23281067, PMID 23606872, PMID 23670165, PMID 23715806, PMID 23953605, PMID 24848086, PMID 24904204, PMID 25132340, PMID 25400065, PMID 25586473, PMID 25596361, PMID 26384156, PMID 26491706, PMID 26945271, PMID 27350947, PMID 27378135, PMID 27617867, PMID 28615976, PMID 28656519, PMID 29300292, PMID 29385990, PMID 30142847, PMID 30776530, PMID 30862384, PMID 31039103, PMID 32791124, PMID 33870822, PMID 34905749, PMID 35363563, PMID 35536667, PMID 35622269, PMID 37930264, PMID 39833952, PMID 40029222, PMID 40135809, PMID 40836399, PMID 42057482, PMID 42311071, PMID 42781031, PMID 6805716

NIH funding

2023 (1), R01AG047894 (1), R44DK121578 (1)